Maravai Lifesciences Holdings Inc (MRVI) — Working Capital to Net Assets Ratio
Maravai Lifesciences Holdings Inc (MRVI) has a Working Capital to Net Assets ratio of 61.2% as of September 2025. Working capital of $264.29 Million (current assets of $325.87 Million minus current liabilities of $61.57 Million) is measured against net assets of $431.86 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Maravai Lifesciences Holdings Inc balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Maravai Lifesciences Holdings Inc Working Capital to Net Assets (2018–2024)
This chart shows how Maravai Lifesciences Holdings Inc's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2018 to 2024. As of September 2025, the ratio stands at 61.2%, reflecting working capital of $264.29 Million against net assets of $431.86 Million USD. Check Maravai Lifesciences Holdings Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Maravai Lifesciences Holdings Inc (2018–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Maravai Lifesciences Holdings Inc from 2018 to 2024, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Maravai Lifesciences Holdings Inc (MRVI) total market value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 64.5% | $372.18 Million | $577.21 Million | $429.15 Million | $56.97 Million | ▼ -13.1 pp |
| 2023 | 77.5% | $612.44 Million | $789.88 Million | $699.91 Million | $87.47 Million | ▼ -4.0 pp |
| 2022 | 81.5% | $737.76 Million | $905.24 Million | $847.90 Million | $110.14 Million | ▼ -37.0 pp |
| 2021 | 118.5% | $646.26 Million | $545.36 Million | $740.04 Million | $93.78 Million | ▼ -11.3 pp |
| 2020 | 129.8% | $200.82 Million | $154.75 Million | $331.60 Million | $130.78 Million | ▲ +108.3 pp |
| 2019 | 21.4% | $30.99 Million | $144.63 Million | $60.55 Million | $29.56 Million | ▲ +9.3 pp |
| 2018 | 12.1% | $17.88 Million | $148.02 Million | $53.80 Million | $35.92 Million | — |